Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity

por Zillen, Daan, Movig, Kris L. L., Kant, Gert, Masselink, Joost B., Mian, Paola
Publicado 2021

Reply: long-term retention rate of pramipexole in the treatment of Parkinson’s disease

por Arbouw, Maurits E. L., Movig, Kris L. L., van Vugt, Jeroen P. P., Egberts, Toine C. G.
Publicado 2009

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study

por Arbouw, Maurits E. L., Movig, Kris L. L., Guchelaar, Henk-Jan, Neef, Cees, Egberts, Toine C. G.
Publicado 2011

Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar

por Meijboom, Rosanne W., Gardarsdottir, Helga, Becker, Matthijs L., Movig, Kris L. L., Kuijvenhoven, Johan, Egberts, Toine C. G., Giezen, Thijs J.
Publicado 2023

Effect of apomorphine on cognitive performance and sensorimotor gating in humans

por Schellekens, Arnt F. A., Grootens, K. P., Neef, C., Movig, Kris L. L., Buitelaar, J. K., Ellenbroek, B., Verkes, R. J.
Publicado 2009

Prescription behavior for gastroprotective drugs in new users as a result of communications regarding clopidogrel – proton pump inhibitor interaction

por Kruik‐Kollöffel, Willemien J., van der Palen, Job, Kruik, H. Joost, van Herk‐Sukel, Myrthe P. P., Movig, Kris L. L.
Publicado 2016

Does immediate smart feedback on therapy adherence and inhalation technique improve asthma control in children with uncontrolled asthma? A study protocol of the IMAGINE I study

por Sportel, Esther T., Oude Wolcherink, Martijn J., van der Palen, Job, Lenferink, Anke, Thio, Boony J., Movig, Kris L. L., Brusse-Keizer, Marjolein G. J.
Publicado 2020

Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease

por Weernink, Marieke G. M., van Til, Janine A., van Vugt, Jeroen P. P., Movig, Kris L. L., Groothuis-Oudshoorn, Catharina G. M., IJzerman, Maarten J.
Publicado 2016

Pharmacotherapy within a learning healthcare system: rationale for the Dutch Santeon Farmadatabase

por van de Garde, Ewoudt M W, Plouvier, Bram C, Fleuren, Hanneke W H A, Haak, Eric A F, Movig, Kris L L, Deenen, Maarten J, van Hulst, Marinus
Publicado 2019

Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retro...

por Kruik-Kollöffel, Willemien J., van der Palen, Job, Doggen, Carine J. M., van Maaren, Marissa C., Kruik, H. Joost, Heintjes, Edith M., Movig, Kris L. L., Linssen, Gerard C. M.
Publicado 2020

Switching TNFα inhibitors: Patterns and determinants

por Meijboom, Rosanne W., Gardarsdottir, Helga, Becker, Matthijs L., de Groot, Mark C. H., Movig, Kris L. L., Kuijvenhoven, Johan, Egberts, Toine C. G., Leufkens, Hubert G. M., Giezen, Thijs J.
Publicado 2021

Study protocol for a randomised controlled trial on the effect of local analgesia for pain relief after minimal invasive sacroiliac joint fusion: the ARTEMIS study

por Hermans, Sem M M, Nellensteijn, Jorm M, van Santbrink, Henk, Knoef, Rob, Reinders, Mattheus K, Hoofwijk, Daisy M N, Potters, Jan W, Movig, Kris L L, Curfs, Inez, van Hemert, Wouter L W
Publicado 2021

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease

por Arbouw, Maurits E. L., Movig, Kris L. L., Egberts, Toine C. G., Poels, Petra J. E., van Vugt, Jeroen P. P., Wessels, Judith A. M., van der Straaten, R. J. H. M., Neef, Cees, Guchelaar, Henk-Jan
Publicado 2009